APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Breakthrough Therapies

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Breakthrough Therapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174082110315 April 2026186 pages

Choose your research edition.

Industry ResearchBreakthrough Therapies Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Breakthrough Therapies Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Breakthrough Therapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breakthrough Therapies Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Breakthrough Therapies Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Breakthrough Therapies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Breakthrough Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Breakthrough Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Breakthrough Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Breakthrough Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Breakthrough Therapies include F. Hoffmann-La Roche, Merck & Co., Bristol-Myers Squibb, Novartis, AstraZeneca, Johnson & Johnson, Pfizer and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Breakthrough Therapies market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Breakthrough Therapies and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Breakthrough Therapies revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Breakthrough Therapies market size, projected growth trends, production technologies, key applications, and end-use industries.

Breakthrough Therapies Segment by Company

F. Hoffmann-La Roche

Merck & Co.

Bristol-Myers Squibb

Novartis

AstraZeneca

Johnson & Johnson

Pfizer

AbbVie

Breakthrough Therapies Segment by Type

Targeted Therapy

Immunotherapy

Gene Therapy

Cell Therapy

Other

Breakthrough Therapies Segment by Application

Cardiovascular

Central Nervous System and Neurology

Rare Diseases

Oncology

Others

Breakthrough Therapies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breakthrough Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breakthrough Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breakthrough Therapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Breakthrough Therapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Breakthrough Therapies industry.

Chapter 3: Detailed analysis of Breakthrough Therapies companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breakthrough Therapiesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Breakthrough Therapies Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Targeted Therapy Table 3. Key Players of Immunotherapy Table 4. Key Players of Gene Therapy Table 3. Key Players of Cell Therapy Table 4. Key Players of Other Table 5. Global Breakthrough Therapies Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Cardiovascular Table 7. Key Players of Central Nervous System and Neurology Table 8. Key Players of Rare Diseases Table 9. Key Players of Oncology Table 10. Key Players of Others Table 11. Global Breakthrough Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Breakthrough Therapies Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Breakthrough Therapies Market Share by Region (2021-2026) Table 14. Global Breakthrough Therapies Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Breakthrough Therapies Market Share by Region (2027-2032) Table 16. Breakthrough Therapies Industry Trends Table 17. Breakthrough Therapies Industry Drivers Table 18. Breakthrough Therapies Industry Opportunities and Challenges Table 19. Breakthrough Therapies Industry Restraints Table 20. Global Breakthrough Therapies Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Breakthrough Therapies Revenue Market Share by Company (2021-2026) Table 22. Global Breakthrough Therapies Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Breakthrough Therapies Key Company Head Office and Area Served Table 24. Global Breakthrough Therapies Company, Product Type & Application Table 25. Global Breakthrough Therapies Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Breakthrough Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Breakthrough Therapies Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Breakthrough Therapies Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Breakthrough Therapies Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Breakthrough Therapies Revenue Market Share by Type (2021-2026) Table 32. Global Breakthrough Therapies Revenue Market Share by Type (2027-2032) Table 33. Global Breakthrough Therapies Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Breakthrough Therapies Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Breakthrough Therapies Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Breakthrough Therapies Revenue Market Share by Application (2021-2026) Table 37. Global Breakthrough Therapies Revenue Market Share by Application (2027-2032) Table 38. F. Hoffmann-La Roche Company Information Table 39. F. Hoffmann-La Roche Business Overview Table 40. F. Hoffmann-La Roche Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. F. Hoffmann-La Roche Breakthrough Therapies Product Portfolio Table 42. F. Hoffmann-La Roche Recent Development Table 43. Merck & Co. Company Information Table 44. Merck & Co. Business Overview Table 45. Merck & Co. Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Merck & Co. Breakthrough Therapies Product Portfolio Table 47. Merck & Co. Recent Development Table 48. Bristol-Myers Squibb Company Information Table 49. Bristol-Myers Squibb Business Overview Table 50. Bristol-Myers Squibb Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Bristol-Myers Squibb Breakthrough Therapies Product Portfolio Table 52. Bristol-Myers Squibb Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Novartis Breakthrough Therapies Product Portfolio Table 57. Novartis Recent Development Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. AstraZeneca Breakthrough Therapies Product Portfolio Table 62. AstraZeneca Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Johnson & Johnson Breakthrough Therapies Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Pfizer Breakthrough Therapies Product Portfolio Table 72. Pfizer Recent Development Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. AbbVie Breakthrough Therapies Product Portfolio Table 77. AbbVie Recent Development Table 78. North America Breakthrough Therapies Market Size by Type (2021-2026) & (US$ Million) Table 79. North America Breakthrough Therapies Market Size by Type (2027-2032) & (US$ Million) Table 80. North America Breakthrough Therapies Market Size by Application (2021-2026) & (US$ Million) Table 81. North America Breakthrough Therapies Market Size by Application (2027-2032) & (US$ Million) Table 82. North America Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. North America Breakthrough Therapies Market Size by Country (2021-2026) Table 84. North America Breakthrough Therapies Market Size by Country (2027-2032) Table 85. Europe Breakthrough Therapies Market Size by Type (2021-2026) & (US$ Million) Table 86. Europe Breakthrough Therapies Market Size by Type (2027-2032) & (US$ Million) Table 87. Europe Breakthrough Therapies Market Size by Application (2021-2026) & (US$ Million) Table 88. Europe Breakthrough Therapies Market Size by Application (2027-2032) & (US$ Million) Table 89. Europe Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. Europe Breakthrough Therapies Market Size by Country (2021-2026) Table 91. Europe Breakthrough Therapies Market Size by Country (2027-2032) Table 92. China Breakthrough Therapies Market Size by Type (2021-2026) & (US$ Million) Table 93. China Breakthrough Therapies Market Size by Type (2027-2032) & (US$ Million) Table 94. China Breakthrough Therapies Market Size by Application (2021-2026) & (US$ Million) Table 95. China Breakthrough Therapies Market Size by Application (2027-2032) & (US$ Million) Table 96. Asia Breakthrough Therapies Market Size by Type (2021-2026) & (US$ Million) Table 97. Asia Breakthrough Therapies Market Size by Type (2027-2032) & (US$ Million) Table 98. Asia Breakthrough Therapies Market Size by Application (2021-2026) & (US$ Million) Table 99. Asia Breakthrough Therapies Market Size by Application (2027-2032) & (US$ Million) Table 100. Asia Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Asia Breakthrough Therapies Market Size by Country (2021-2026) Table 102. Asia Breakthrough Therapies Market Size by Country (2027-2032) Table 103. South America, Middle East & Africa Breakthrough Therapies Market Size by Type (2021-2026) & (US$ Million) Table 104. South America, Middle East & Africa Breakthrough Therapies Market Size by Type (2027-2032) & (US$ Million) Table 105. South America, Middle East & Africa Breakthrough Therapies Market Size by Application (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Breakthrough Therapies Market Size by Application (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. South America, Middle East & Africa Breakthrough Therapies Market Size by Country (2021-2026) Table 109. South America, Middle East & Africa Breakthrough Therapies Market Size by Country (2027-2032) Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Breakthrough Therapies Product Image Figure 2. Global Breakthrough Therapies Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Breakthrough Therapies Market Share by Type: 2025 VS 2032 Figure 4. Targeted Therapy Image Figure 5. Immunotherapy Image Figure 6. Gene Therapy Image Figure 7. Cell Therapy Image Figure 8. Other Image Figure 9. Global Breakthrough Therapies Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Breakthrough Therapies Market Share by Application: 2025 VS 2032 Figure 11. Cardiovascular Image Figure 12. Central Nervous System and Neurology Image Figure 13. Rare Diseases Image Figure 14. Oncology Image Figure 15. Others Image Figure 16. Global Breakthrough Therapies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 18. Global Breakthrough Therapies Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Breakthrough Therapies Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Breakthrough Therapies Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Breakthrough Therapies Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Breakthrough Therapies Revenue Market Share by Type (2021-2032) Figure 25. Global Breakthrough Therapies Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Breakthrough Therapies Revenue Market Share by Application (2021-2032) Figure 27. North America Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 28. North America Breakthrough Therapies Market Share by Type (2021-2032) Figure 29. North America Breakthrough Therapies Market Share by Application (2021-2032) Figure 30. North America Breakthrough Therapies Market Share by Country (2021-2032) Figure 31. United States Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 32. Canada Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 34. Europe Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 35. Europe Breakthrough Therapies Market Share by Type (2021-2032) Figure 36. Europe Breakthrough Therapies Market Share by Application (2021-2032) Figure 37. Europe Breakthrough Therapies Market Share by Country (2021-2032) Figure 38. Germany Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 39. France Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 41. Italy Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 42. Russia Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 44. China Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 45. China Breakthrough Therapies Market Share by Type (2021-2032) Figure 46. China Breakthrough Therapies Market Share by Application (2021-2032) Figure 47. Asia Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 48. Asia Breakthrough Therapies Market Share by Type (2021-2032) Figure 49. Asia Breakthrough Therapies Market Share by Application (2021-2032) Figure 50. Asia Breakthrough Therapies Market Share by Country (2021-2032) Figure 51. Japan Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 55. India Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 56. Australia Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Breakthrough Therapies Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Breakthrough Therapies Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Breakthrough Therapies Market Share by Country (2021-2032) Figure 61. Brazil Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 66. UAE Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 68. Chile Breakthrough Therapies Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Therapy
  • Immunotherapy
  • Gene Therapy
  • Cell Therapy
  • Other
Applications
  • Cardiovascular
  • Central Nervous System and Neurology
  • Rare Diseases
  • Oncology
  • Others
Companies covered
  • F. Hoffmann-La Roche
  • Merck & Co.
  • Bristol-Myers Squibb
  • Novartis
  • AstraZeneca
  • Johnson & Johnson
  • Pfizer
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Breakthrough Therapies Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Therapy
  5. 1.2.3 Immunotherapy
  6. 1.2.4 Gene Therapy
  7. 1.2.5 Cell Therapy
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Breakthrough Therapies Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Cardiovascular
  12. 1.3.3 Central Nervous System and Neurology
  13. 1.3.4 Rare Diseases
  14. 1.3.5 Oncology
  15. 1.3.6 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Breakthrough Therapies Growth Trends by Region
  18. 1.5.1 Global Breakthrough Therapies Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Breakthrough Therapies Market Size by Region (2021-2026)
  20. 1.5.3 Breakthrough Therapies Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Breakthrough Therapies Market Dynamics
  1. 2.1 Breakthrough Therapies Industry Trends
  2. 2.2 Breakthrough Therapies Industry Drivers
  3. 2.3 Breakthrough Therapies Industry Opportunities and Challenges
  4. 2.4 Breakthrough Therapies Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Breakthrough Therapies Revenue by Company (2021-2026)
  2. 3.2 Global Breakthrough Therapies Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Breakthrough Therapies Key Company Head office and Area Served
  4. 3.4 Global Breakthrough Therapies Company, Product Type & Application
  5. 3.5 Global Breakthrough Therapies Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Breakthrough Therapies Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Breakthrough Therapies Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Breakthrough Therapies Tier 1, Tier 2, and Tier 3
4 Breakthrough Therapies Market by Type
  1. 4.1 Global Breakthrough Therapies Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Breakthrough Therapies Market Size by Type (2021-2032)
  3. 4.3 Global Breakthrough Therapies Market Size Share by Type (2021-2032)
5 Breakthrough Therapies Market by Application
  1. 5.1 Global Breakthrough Therapies Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Breakthrough Therapies Market Size by Application (2021-2032)
  3. 5.3 Global Breakthrough Therapies Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 F. Hoffmann-La Roche
  2. 6.1.1 F. Hoffmann-La Roche Company Information
  3. 6.1.2 F. Hoffmann-La Roche Business Overview
  4. 6.1.3 F. Hoffmann-La Roche Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 F. Hoffmann-La Roche Breakthrough Therapies Product Portfolio
  6. 6.1.5 F. Hoffmann-La Roche Recent Developments
  7. 6.2 Merck & Co.
  8. 6.2.1 Merck & Co. Company Information
  9. 6.2.2 Merck & Co. Business Overview
  10. 6.2.3 Merck & Co. Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck & Co. Breakthrough Therapies Product Portfolio
  12. 6.2.5 Merck & Co. Recent Developments
  13. 6.3 Bristol-Myers Squibb
  14. 6.3.1 Bristol-Myers Squibb Company Information
  15. 6.3.2 Bristol-Myers Squibb Business Overview
  16. 6.3.3 Bristol-Myers Squibb Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Breakthrough Therapies Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Breakthrough Therapies Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Breakthrough Therapies Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Johnson & Johnson
  32. 6.6.1 Johnson & Johnson Company Information
  33. 6.6.2 Johnson & Johnson Business Overview
  34. 6.6.3 Johnson & Johnson Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Johnson & Johnson Breakthrough Therapies Product Portfolio
  36. 6.6.5 Johnson & Johnson Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer Breakthrough Therapies Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 AbbVie
  44. 6.8.1 AbbVie Company Information
  45. 6.8.2 AbbVie Business Overview
  46. 6.8.3 AbbVie Breakthrough Therapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 AbbVie Breakthrough Therapies Product Portfolio
  48. 6.8.5 AbbVie Recent Developments
7 North America
  1. 7.1 North America Breakthrough Therapies Market Size (2021-2032)
  2. 7.2 North America Breakthrough Therapies Market Size by Type
  3. 7.2.1 North America Breakthrough Therapies Market Size by Type (2021-2026)
  4. 7.2.2 North America Breakthrough Therapies Market Size by Type (2027-2032)
  5. 7.2.3 North America Breakthrough Therapies Market Share by Type (2021-2032)
  6. 7.3 North America Breakthrough Therapies Market Size by Application
  7. 7.3.1 North America Breakthrough Therapies Market Size by Application (2021-2026)
  8. 7.3.2 North America Breakthrough Therapies Market Size by Application (2027-2032)
  9. 7.3.3 North America Breakthrough Therapies Market Share by Application (2021-2032)
  10. 7.4 North America Breakthrough Therapies Market Size by Country
  11. 7.4.1 North America Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Breakthrough Therapies Market Size by Country (2021-2026)
  13. 7.4.3 North America Breakthrough Therapies Market Size by Country (2027-2032)
  14. 7.4.4 North America Breakthrough Therapies Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Breakthrough Therapies Market Size (2021-2032)
  2. 8.2 Europe Breakthrough Therapies Market Size by Type
  3. 8.2.1 Europe Breakthrough Therapies Market Size by Type (2021-2026)
  4. 8.2.2 Europe Breakthrough Therapies Market Size by Type (2027-2032)
  5. 8.2.3 Europe Breakthrough Therapies Market Share by Type (2021-2032)
  6. 8.3 Europe Breakthrough Therapies Market Size by Application
  7. 8.3.1 Europe Breakthrough Therapies Market Size by Application (2021-2026)
  8. 8.3.2 Europe Breakthrough Therapies Market Size by Application (2027-2032)
  9. 8.3.3 Europe Breakthrough Therapies Market Share by Application (2021-2032)
  10. 8.4 Europe Breakthrough Therapies Market Size by Country
  11. 8.4.1 Europe Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Breakthrough Therapies Market Size by Country (2021-2026)
  13. 8.4.3 Europe Breakthrough Therapies Market Size by Country (2027-2032)
  14. 8.4.4 Europe Breakthrough Therapies Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Breakthrough Therapies Market Size (2021-2032)
  2. 9.2 China Breakthrough Therapies Market Size by Type
  3. 9.2.1 China Breakthrough Therapies Market Size by Type (2021-2026)
  4. 9.2.2 China Breakthrough Therapies Market Size by Type (2027-2032)
  5. 9.2.3 China Breakthrough Therapies Market Share by Type (2021-2032)
  6. 9.3 China Breakthrough Therapies Market Size by Application
  7. 9.3.1 China Breakthrough Therapies Market Size by Application (2021-2026)
  8. 9.3.2 China Breakthrough Therapies Market Size by Application (2027-2032)
  9. 9.3.3 China Breakthrough Therapies Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Breakthrough Therapies Market Size (2021-2032)
  2. 10.2 Asia Breakthrough Therapies Market Size by Type
  3. 10.2.1 Asia Breakthrough Therapies Market Size by Type (2021-2026)
  4. 10.2.2 Asia Breakthrough Therapies Market Size by Type (2027-2032)
  5. 10.2.3 Asia Breakthrough Therapies Market Share by Type (2021-2032)
  6. 10.3 Asia Breakthrough Therapies Market Size by Application
  7. 10.3.1 Asia Breakthrough Therapies Market Size by Application (2021-2026)
  8. 10.3.2 Asia Breakthrough Therapies Market Size by Application (2027-2032)
  9. 10.3.3 Asia Breakthrough Therapies Market Share by Application (2021-2032)
  10. 10.4 Asia Breakthrough Therapies Market Size by Country
  11. 10.4.1 Asia Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Breakthrough Therapies Market Size by Country (2021-2026)
  13. 10.4.3 Asia Breakthrough Therapies Market Size by Country (2027-2032)
  14. 10.4.4 Asia Breakthrough Therapies Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Breakthrough Therapies Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Breakthrough Therapies Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Breakthrough Therapies Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Breakthrough Therapies Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Breakthrough Therapies Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Breakthrough Therapies Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Breakthrough Therapies Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Breakthrough Therapies Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Breakthrough Therapies Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Breakthrough Therapies Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Breakthrough Therapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Breakthrough Therapies Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Breakthrough Therapies Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Breakthrough Therapies Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst